Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Investing News Network on MSN
5 best-performing Canadian uranium stocks of 2025
The uranium market moved through 2025 with less drama than the previous year, but the quieter tone masked a sector still tightening beneath the surface. After 2024’s surge to two-decade highs, in 2025 ...
The ASX Healthcare sector has finished the week of December 19, 2025 down 1.6% with few signs of a much needed Christmas ...
Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patientThe ACTION3 Phase 3 trial explores the efficacy and safety ...
ACTION3 is a pivotal multicentre, randomised, double-blind, placebo-controlled study of the efficacy and safety of DMX-200 in ...
(“DIMERx”), a clinical-stage biopharmaceutical company developing first-in-class dimer-based therapeutics for major public-health needs, today announced the appointment of Lee S. Simon, MD, former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback